|
[1] Bergeron J, Hebert B, Tijssen P. Genome organization of the Kresse strain of porcine parvovirus: identification of the allotropic determinant and comparison with those of NADL-2 and field isolates. Journal Of Virology, 1996, 70(4):2508-2515.
[2] Dunne H W, Gobble J L, Hokanson J F. Porcine reproductive failure associated with a newly identified'SMEDI' group of picorna viruses. American Journal of Veterinary Research, 1965, 26(2): 1284-1297.
[3] Mengeling W L, Cutlip R C. Pathogenesis of in utero infection: experimental infection of five-week-old porcine fetuses with porcine parvovirus. American Journal of Veterinary Research, 1975, 36(8): 1173-1177.
[4] Joo H S, Donaldson-Wood C R, Johnson R H. Observations on the pathogenesis of porcine parvovirus infection. Archives of Virology, 1976, 51(2): 123-129.
[5] Suzuki H, Fujisaki Y. Immunizing effect of inactivated porcine parvovirus vaccine on piglets. National Institute of Animal Health Quarterly, 1976, 16(2): 78-81.
[6] Joo H S, Johnson R H. Serological responses in pigs vaccinated with inactivated porcine parvovirus. Australian Veterinary Journal, 1977, 53(4): 550-552.
[7] Fujisaki Y, Ichihara T, Sasaki N. Field trials on inactivated porcine parvovirus vaccine for prevention of viral stillbirth among swine. National Institute of Animal Health Quarterly, 1978, 18(3): 180-185.
[8] Mengeling W L, Brown T T, Paul P S, et al. Efficacy of an inactivated virus vaccine for prevention of porcine parvovirus-induced reproductive failure. American Journal of Veterinary Research, 1979, 40(7): 204-207.
[9] Wrathall A E, Wells D E, Cartwright S F, et al. An inactivated, oil-emulsion vaccine for the prevention of porcine parvovirus-induced reproductive failure. Research in Veterinary Science, 1984, 36(5): 136-143.
[10] Vannier P, Brun A, Chappuis G, et al. Study of the efficacy of an inactivated virus vaccine against porcine parvovirus. Annales de Recherches Vétérinaires, 1986, 17(4): 425-432.
[11] Wrathall A E. Field trials of an inactivated, oil-emulsion porcine parvovirus vaccine in British pig herds. Veterinary Record, 1988, 122(1): 411-418.
[12] Kradowks, Ellis J A, Meehan B. Viral wastingsyndrome of swine: experimental reproduction of postweaning multisystemic wasting syndrome in gnotobiotic swine by coinfection with circovirus2 and porcine parvovirus. VetPathol, 2000, 37(3): 254-263.
[13] Oraveeerakul K, Sooccchoi C, Molitor T W. Detection of porcine parvovirus using nonradioactive nucleic acid hybridization. Vet Diagn Inreat, 1990, 36(2): 85-91.
[14] Van Wezel A. Growth of cell-strains and primary cells on micro-carriers in homogeneous culture. Nature, 1967, 21(6): 64-65.
[15] Tree J A, Richardson C, Fooks A R, et al. Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains. Vaccine, 2001, 19(25-26): 3444-3450.
[16] Mengeling W L, Pejsak Z, Paul P S. Biological assay of attenuated strain NADL-2 and virulent strain NADL-8 of porcine parvovirus. Am J Vet.Res, 1984, 45(11): 2403-2407.
[17] Kunal A, Frank J, Luis M, et al. Bioprocess optimization for cell culture based influenza vaccine production. Vaccine, 2011, 29(17): 3320-3328.
[18] 杨琴, 张兴晓, 杨灵芝. ３种细胞培养流感病毒的比较. 动物医学进展, 2009,30(11):76-79. Yang Q, Zhang X X, Yang L Z. Comparison of cultureing influenza virus in three kinds of cell lines. Progress In Veterinary Medicine, 2009,30(11):76-79.
[19] 魏战勇, 崔保安, 张素梅, 等. 猪细小病毒在PK细胞中的增殖过程. 中国兽医学报, 2005,25(5):453-455. Wei Z Y, Cui B A, Zhang S M, et al. The replication of porcine parvovirus in PK-15 cell cultures. Chinese Journal Of Veterinary Science, 2005,25(5):453-455.
|
